Expression of blood dendritic cell antigens (BDCAs) by CD1a+ human pulmonary cells

Maria Tsoumakidou1, Sarah J Kemp, Andrew J Thorley

  • 1Lung Pathology Unit, London SW3 6LY, UK. tsoumak@yahoo.gr

Respiratory Medicine
|March 31, 2009
PubMed

Insights

Human pulmonary CD1a(+) dendritic cells (DCs) can express both myeloid and plasmacytoid Blood DC Antigens (BDCAs). This suggests experimental induction of flexibility in lung DC subsets, rather than strict subset restriction.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Human lung dendritic cells (DCs) comprise distinct myeloid and plasmacytoid subsets defined by Blood DC Antigen (BDCA) expression.
  • Langerhan's cells are a subset of CD1a(+) dendritic cells found in the human lung.

Purpose of the Study:

  • To investigate the expression of myeloid and plasmacytoid BDCA markers on isolated human pulmonary CD1a(+) dendritic cells (Langerhan's cells).

Main Methods:

  • Isolation of CD1a(+) cells from human lung tissue using an in vitro cell culture system.
  • Immunophenotypic analysis using antibodies against BDCA1, BDCA3, BDCA2, Langerin, and CD83.

Main Results:

  • Isolated CD1a(+) cells exhibited variable expression of Langerin, BDCAs, and CD83 across samples.
  • A subset of mature CD1a(+) cells expressed all tested BDCA markers, indicating co-expression.

Conclusions:

  • Pulmonary CD1a(+) dendritic cells can express both myeloid and plasmacytoid BDCA markers in vitro.
  • Experimental conditions can induce flexibility or plasticity in pulmonary DC subset marker expression.
Abstract